Hyun Soo Cho

Title: Hyun Soo Cho: Innovator in Target-Specific Non-Antibody Proteins

Introduction

Hyun Soo Cho is a prominent inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of target-specific non-antibody proteins. His innovative work has the potential to impact cancer therapeutics significantly.

Latest Patents

Hyun Soo Cho holds a patent for a "Target-specific non-antibody protein and method for preparing the same." This invention relates to a method for preparing a target-specific non-antibody protein. The process involves selecting non-antibody proteins that have structural complementarity with the target site of a target protein from a non-antibody protein library. The method includes calculating the binding energy of the selected non-antibody protein and the target protein, selecting a non-antibody protein with favorable binding energy, and substituting specific amino acid residues to enhance binding affinity. Notably, this invention includes a target-specific non-antibody that binds specifically to the EGFR (Epidermal Growth Factor Receptor) domain 2, which is crucial for developing cancer therapeutic compositions.

Career Highlights

Hyun Soo Cho is associated with the Postech Academy-Industry Foundation, where he continues to advance his research and innovations. His work is characterized by a strong focus on practical applications in medicine and biotechnology.

Collaborations

Hyun Soo Cho collaborates with notable colleagues, including Yoon Sup Choi and Jun Ho Chung. Their combined expertise contributes to the advancement of research in their field.

Conclusion

Hyun Soo Cho's innovative work in developing target-specific non-antibody proteins showcases his commitment to advancing biotechnology and cancer treatment. His contributions are paving the way for new therapeutic options in the medical field.